Literature DB >> 12881485

A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site.

Y Kate Hong1, Aki Mikami, Brian Schaffhausen, Toni Jun, Thomas M Roberts.   

Abstract

Previous studies have demonstrated that the specificity of Src homology 2 (SH2) and phosphotyrosine-binding domain interactions are mediated by phosphorylated tyrosines and their neighboring amino acids. Two of the first phosphotyrosine-based binding sites were found on middle T antigen of polyoma virus. Tyr-250 acts as a binding site for ShcA, whereas Tyr-315 forms a binding site for the SH2 domain of the p85 subunit of phosphatidylinositol 3-kinase. However, genetic analysis of a given phosphotyrosine's role in signaling can be complicated when it serves as a binding site for multiple proteins. The situation is particularly difficult when the phosphotyrosine serves as a secondary binding site for a protein with primary binding determinates elsewhere. Mutation of a tyrosine residue to phenylalanine blocks association of all bound proteins. Here we show that the mutation of the amino acids following the phosphorylated tyrosine to alanine can reveal phosphotyrosine function as a secondary binding site, while abrogating the phosphotyrosine motif's role as a primary binding site for SH2 domains. We tested this methodology by using middle T antigen. Our results suggest that Tyr-250 is a secondary binding site for phosphatidylinositol 3-kinase, whereas Tyr-315 is a secondary binding site for a yet-to-be-identified protein, which is critical for transformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881485      PMCID: PMC170936          DOI: 10.1073/pnas.1432964100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Association of the polyomavirus middle-T antigen with c-yes protein.

Authors:  S Kornbluth; M Sudol; H Hanafusa
Journal:  Nature       Date:  1987 Jan 8-14       Impact factor: 49.962

2.  Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production.

Authors:  D C Pallas; C Schley; M Mahoney; E Harlow; B S Schaffhausen; T M Roberts
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

3.  Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.

Authors:  W Markland; B A Oostra; R Harvey; A F Markham; W H Colledge; A E Smith
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Phosphatidylinositol metabolism and polyoma-mediated transformation.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; L Raptis; R L Garcea; D Pallas; T M Roberts; L Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; D C Pallas; M White; L Cantley; T M Roberts
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

6.  An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.

Authors:  S A Courtneidge; A Heber
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

Review 7.  Mutants of polyomavirus middle-T antigen.

Authors:  W Markland; A E Smith
Journal:  Biochim Biophys Acta       Date:  1987-11-25

8.  Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.

Authors:  M Whitman; C P Downes; M Keeler; T Keller; L Cantley
Journal:  Nature       Date:  1988-04-14       Impact factor: 49.962

9.  Identification and characterization of p59fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells.

Authors:  R M Kypta; A Hemming; S A Courtneidge
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

10.  Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus.

Authors:  S H Cheng; R Harvey; P C Espino; K Semba; T Yamamoto; K Toyoshima; A E Smith
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  5 in total

1.  Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.

Authors:  Kerry A Whalen; Georg F Weber; Thomas L Benjamin; Brian S Schaffhausen
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

2.  The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.

Authors:  Tamara Utermark; Brian S Schaffhausen; Thomas M Roberts; Jean J Zhao
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

Review 3.  Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.

Authors:  Brian S Schaffhausen; Thomas M Roberts
Journal:  Virology       Date:  2008-11-20       Impact factor: 3.616

Review 4.  PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication.

Authors:  Mulu Geletu; Zaid Taha; Patrick T Gunning; Leda Raptis
Journal:  Cancers (Basel)       Date:  2019-02-01       Impact factor: 6.639

5.  PRL-3 activates mTORC1 in Cancer Progression.

Authors:  Zu Ye; Abdul Qader Omer Al-Aidaroos; Jung Eun Park; Hiu Fung Yuen; Shu Dong Zhang; Abhishek Gupta; Youbin Lin; Han-Ming Shen; Qi Zeng
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.